EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT)

Mengyan Hou, Xia Li, Yan Li iD, Wenhao Shi, Haotian Tang, Fang Feng, Xuan Wan, Hua Xie, Guilong Zhao iD

Molecules · 08.04.2026 · 31 (8) · 1230

DOI: 10.3390/molecules31081230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 08.04.2026. Verfasst von Mengyan Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Boron, Sugars, Boron Compounds. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Funds of National Natural Science Foundation of China, Zhongshan Municipal Natural Science Foundation, Creative Research Group of Zhongshan City (Lingnan Pharmaceutical Research and Innovation team).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is one of the conventional methods for the treatment of cancers. Boron neutron capture therapy (BNCT) has emerged as a promising and well-recognized modality for treating certain types of cancers. BNCT is a binary radiotherapy that largely depends on neutron beams and 10B carriers. Although an “ideal” boron carrier should fulfill multiple criteria, high tumor/normal tissue ratio (T/N > 5) and high tumor uptake of boron (>20 μg/g) are critically important. First-generation (boric acid and derivatives) and second-generation (BPA and BSH) boron carriers suffer from poor T/N and extremely high dose in clinical use (500 mg/kg and usually >30 g for each patient). Glucose transporter 1 (GLUT1) is overexpressed on the membrane surface of multiple tumors and is a potential target for third-generation boron carrier to achieve high T/N and high tumor uptake of boron. However, the boron-bearing sugar derivatives designed in the last few decades have suffered from suboptimal T/N values and significant cytotoxicity. In the present study, a total of two categories comprising 6 series (28 in total) of boron-bearing sugar derivatives were designed and synthesized and their cellular boron uptake, T/N, and cytotoxicity were evaluated. The structure–activity relationship (SAR) of these target compounds was analyzed, and one of the target compounds, B3, a phenyl C-mannoside with an o-carborane moiety, exhibited the best boron-carrying profile, which featured 10.6-fold higher boron uptake by the SCC-9 cell line and a largely improved T/N (3.3 for B3 vs. 1.4 for BPA) compared with the current clinical gold standard BPA. Therefore, the chemical structure of B3 represents a privileged candidate structure for the future design of “ideal” boron carriers for BNCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyBoronSugarsBoron CompoundsHumansCell Line, TumorGlucose Transporter Type 1

Stichwörter der Autor:innen

BNCTGLUT1boron neutron capture therapycarbohydratesugar

Substanzen

BoronSugarsBoron CompoundsGlucose Transporter Type 1

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

ORCID-Profile: Yan Li, Guilong Zhao

Förderung

  • Special Funds of National Natural Science Foundation of China
  • Zhongshan Municipal Natural Science Foundation
  • Creative Research Group of Zhongshan City (Lingnan Pharmaceutical Research and Innovation team)
  • National Natural Science Foundation of China

Zitieren

APA

Hou, M., Li, X., Li, Y., Shi, W., Tang, H., Feng, F., Wan, X., Xie, H., & Zhao, G. (2026). Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT). Molecules, 31(8), 1230. https://doi.org/10.3390/molecules31081230

Vancouver

Hou M, Li X, Li Y, Shi W, Tang H, Feng F, et al. Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT). Molecules. 2026;31(8):1230. doi:10.3390/molecules31081230

BibTeX
@article{Hou2026,
  author = {Hou, Mengyan and Li, Xia and Li, Yan and Shi, Wenhao and Tang, Haotian and Feng, Fang and Wan, Xuan and Xie, Hua and Zhao, Guilong},
  title = {Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT)},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {8},
  pages = {1230},
  doi = {10.3390/molecules31081230}
}
Kostenlos starten →